Found 8 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma
PHASE1To assess the maximum tolerated dose and overall safety and tolerability of...
Location
Pfizer Investigational Site
A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study
NAHypothesis: Different patients have different biomarkers, if doctors know a...
Location
Gastrointestinal Hospital, Sun Yat-sen University
N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy
PHASE2The metastatic lesions may be very different from the primary tumor because...
Location
Akershus University Hospital
Molecular Phenotype Changes and Personalized Treatment for CRPC
NATo explore the molecular phenotypic changes and personalized treatment in c...
Location
Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
PHASE2The researchers are doing this study to find out whether adding gefitinib, ...
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer
PHASE21. Metastatic gastric cancer patients who failed standard treatment will be...
Location
Samsung Medical Center